Oxalic Acid

Oxalic Acid

SCHEMBL30909052

Clc1ccc2[nH]cc(C3CCN(CCc4cccc5ccccc45)CC3)c2c1.O=C(O)C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 4/20 0.60
OPRK1 P41145 4/20 0.60
OPRL1 P41146 3/20 0.60
HTR6 P50406 3/20 0.57
KCNH2 Q12809 3/20 0.57
CCR2 P41597 4/20 0.49
ADRA1D P25100 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9031666 0.89 OPRM1 (0.57) OPRM1OPRK1OPRL1HTR6KCNH2
SCHEMBL9030215 0.83 ADRA1D (0.63) OPRM1OPRK1OPRL1ADRA1D
Hydrochloric Acid SCHEMBL9031606 0.80 OPRM1 (0.79) OPRM1OPRK1OPRL1HTR6KCNH2
Oxalic Acid SCHEMBL9048518 0.78 OPRM1 (0.58) OPRM1OPRK1OPRL1HTR6KCNH2
Oxalic Acid SCHEMBL9049148 0.78 OPRM1 (0.55) OPRM1OPRK1OPRL1HTR6KCNH2
SCHEMBL5385661 0.78 OPRM1 (0.64) OPRM1OPRK1OPRL1CCR2ADRA1D
SCHEMBL31143224 0.77 ADRA1D (0.57) OPRM1OPRK1OPRL1HTR6KCNH2
Oxalic Acid SCHEMBL9048237 0.76 OPRM1 (0.55) OPRM1OPRK1OPRL1HTR6KCNH2
SCHEMBL14280723 0.76 OPRM1 (1.00) OPRM1OPRK1OPRL1ADRA1D
Oxalic Acid SCHEMBL9049191 0.76 OPRM1 (0.56) OPRM1OPRK1OPRL1HTR6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073845-A1 METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS VALORISATION HSJ, LIMITED PARTNERSHIP (CA) 2024-04-11 WO disclosed